The results showed that RNF126 knockdown increased p-ATR expression, which meant that the function of ATR protein had been activated, but ATR inhibitors could not effectively kill breast cancer cells with RNF126 knockdown (Fig. 3). The gene discussed is ATR; the disease is breast cancer.